Tembeka Sineke [Researcher - Epidemiology]

T: (0)10 001 2942  
Tembeka Sineke

Tembeka Sineke is an epidemiology researcher in the Health Economics and Epidemiology Research Office of the University of the Witwatersrand. She is currently pursuing a PhD at Maastricht University. She holds a BSc degree in Medical Bioscience from the University of the Western Cape, a BSc Honours degree in Infectious Diseases and Immunology and MPH degree (2015) from the University of Cape Town.

Ms Sineke‚Äôs research has focused on HIV and Tuberculosis. She is currently involved with work that is looking at the impact of the Universal Test and Treat policies and implementation of U=U in South Africa. She is a published author and has contributed to several manuscripts published in peer-reviewed journals such as, “Multi-morbidities Associated with Tuberculosis in South Africa: A Systematic Review of the Literature to name a few”.


  • Rates and predictors of ART refusal under the universal-test-and-treat (UTT) policy in South Africa

    Although almost four of seven million persons living with HIV on antiretroviral therapy (ART), an additional 2.5 million individuals must be initiated on ART to reach the target of initiating 90% of diagnosed HIV positive patients on ART by 2020. However, an estimated 20% of South African patients eligible under CD4<200 eligibility threshold were likely to refuse ART. With the removal of CD4 eligibility thresholds in 2016, it is unclear whether the demand for ART has improved and 
  • Building the Capacity of Lay Health Counsellors to Improve ART Uptake among High CD4 Patients under the “Treat All’ Policy in South Africa

    In September 2016, South Africa began implementing test-and-treat, in which everyone who tests HIV positive is offered antiretroviral therapy (ART), in hopes of attaining the UNAIDS 90-90-90 targets. However the success of the test-and-treat approach depends on early HIV testing and lifelong HIV treatment. In South Africa, lay HIV counselors are the first to introduce ART to newly diagnosed patients. However, most are under-trained with little professional supervision and emotional support and